S&P 500 7,709.96 â–ŧ 13.59 (-0.18%) DOW 53,885.10 â–ŧ 464.02 (-0.85%) NASDAQ 26,348.35 â–ŧ 15.09 (-0.06%) US Markets Closed â€ĸ 02:21 AM ET

STLNW

The Oncology Institute, Inc.

Price Chart
Latest Quote

$0.05

+0.00 (+0.00%)
Current Price
Previous Close $0.05
Open $0.05
Day High $0.05
Day Low $0.05
Volume 2,863
Fetched: 2026-08-07T06:21:16
Stock Information
Total Debt $104.91M
Cash Equivalents $30.28M
Revenue $545.76M
Net Income $-36.32M
Exchange NGM
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Sales$545.76M
Income$-36.32M
Book/sh$-0.16
Employees641
Financial Ratios
Quick Ratio1.13
Current Ratio1.47
Returns & Margins
ROA-12.30%
Gross Margin15.12%
Operating Margin-4.42%
Profit Margin-7.97%
Ownership
Insider & Institutional transactions data not available
Valuation Ratios
P/B-0.31
Analyst Data
Recommendationnone
Technical Indicators
Shares Float86.67M
Volatility0.42
Performance History
YTD+0.00%
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-08-05 $0.05 2,863
About The Oncology Institute, Inc.

Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The company was formerly known as The Oncology Institute, Inc. and changed its name to Starling Oncology, Inc. in August 2026. Starling Oncology, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.